Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer.

Discovery medicine

Volumn 7, Issue 37, 2007, Pages 39-45

  Khatri, Aparajita ^a   Russell, Pamela J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME; PRODRUG;

ANIMAL; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOTHERAPY; MALE; METABOLISM; METHODOLOGY; PROSTATE TUMOR; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; ENZYMES; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; MALE; PRODRUGS; PROSTATIC NEOPLASMS;

EID: 68949106430     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (6)